E-cigarette Nicotine Delivery: Data and Learnings from Pharmacokinetic Studies
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Fearon (2017)
human abuse liability assessment of e-cigarettes: Why, what and how?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Fearon (2022)
a randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Fearon (2022)